These data presented herein indicate that low WDFY3‐AS2 level is a frequent occurring event in multiple tumour types, including ESCC, and may be a novel prognostic factor for multiple different types of tumours, especially for ESCC patients. This evidence concerns the gene WDFY3 and neoplasm.